LifeMD (NASDAQ:LFMD) Sets New 12-Month High at $12.50

LifeMD, Inc. (NASDAQ:LFMD) hit a new 52-week high during trading on Thursday . The company traded as high as $12.50 and last traded at $12.49, with a volume of 602630 shares changing hands. The stock had previously closed at $11.64.

Analysts Set New Price Targets

LFMD has been the topic of a number of recent research reports. HC Wainwright boosted their price target on shares of LifeMD from $10.00 to $12.00 and gave the stock a “buy” rating in a research report on Thursday, January 11th. BTIG Research raised their target price on shares of LifeMD from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Tuesday, April 23rd. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, LifeMD currently has a consensus rating of “Buy” and a consensus target price of $10.40.

LifeMD Price Performance

The stock has a market cap of $510.72 million, a PE ratio of -17.84 and a beta of 1.38. The stock’s fifty day moving average is $9.70 and its 200-day moving average is $7.87. The company has a debt-to-equity ratio of 3.22, a current ratio of 1.22 and a quick ratio of 1.15.

LifeMD (NASDAQ:LFMD) last announced its quarterly earnings results on Monday, March 11th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.02. The firm had revenue of $44.86 million for the quarter, compared to analyst estimates of $40.65 million. As a group, equities analysts anticipate that LifeMD, Inc. will post -0.14 EPS for the current year.

Hedge Funds Weigh In On LifeMD

A number of hedge funds have recently modified their holdings of LFMD. G2 Investment Partners Management LLC increased its position in shares of LifeMD by 23.9% during the fourth quarter. G2 Investment Partners Management LLC now owns 688,050 shares of the company’s stock valued at $5,704,000 after acquiring an additional 132,850 shares during the last quarter. Hsbc Holdings PLC purchased a new stake in shares of LifeMD in the 4th quarter valued at $815,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in LifeMD during the 3rd quarter worth about $577,000. Cantor Fitzgerald L. P. purchased a new position in LifeMD during the 4th quarter valued at about $653,000. Finally, Jump Financial LLC purchased a new position in LifeMD during the 3rd quarter valued at about $465,000. 35.52% of the stock is currently owned by hedge funds and other institutional investors.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.